Legal Representation
Attorney
Scott D. Woldow
USPTO Deadlines
Next Deadline
376 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2020-11-10)
Due Date
November 10, 2026
Grace Period Ends
May 10, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
18 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 10, 2020 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Aug 25, 2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Aug 25, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Aug 5, 2020 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jul 19, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jul 19, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jul 19, 2020 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jul 13, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Apr 20, 2020 | EPEN | O | COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY | Loading... |
| Apr 20, 2020 | GEAP | F | EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | Loading... |
| Apr 20, 2020 | GEAN | O | NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | Loading... |
| Apr 20, 2020 | CPEA | R | EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED | Loading... |
| Apr 18, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 18, 2020 | AMPX | O | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | Loading... |
| Feb 13, 2020 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Feb 7, 2020 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | Loading... |
| Feb 4, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 1, 2020 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
pharmaceutical preparations for human use for the treatment of neurological diseases and disorders, immunological diseases and disorders, inflammatory diseases and disorders, oncological diseases and disorders and viral infections; pharmaceutical preparations for the treatment of CAR T-cell induced cytokine release syndrome
Classification
International Classes
005